Corporate Magazine 2012 - Boehringer Ingelheim

Vitamins and supplementspharmaton® capsules/tablets is a multivitamin and mineralsupplements brand developed to support physicaland mental well-being. A full range of products adaptedto the needs of different target audiences has been developedthat work in harmony with the body.pharmaton® vitality, a range of products for adults,contains a selected blend of vitamins, minerals and traceelements and standardised Ginseng extract G115®. Themain target indications are: exhaustion, tiredness, decreasingconcentration and mental alertness, as well as incases of deficient nutrition, loss of appetite, debility dueto illness and convalescence. Numerous clinical studieshave shown that a regular intake of pharmaton® has apositive effect on mental and physical performance andwell-being.pharmaton® matruelle® is indicated for women who areactively planning to get pregnant, pregnant women andbreastfeeding women, and contains all important micronutrientsfor mother and baby, such as vitamins, mineralsand omega-3 fatty acids, to cover the increased needs forthese substances in those particular periods. Moreover, ithelps to protect against embryonal neural tube diseases ofthe foetus and against iron and folic acid anaemia duringpregnancy.pharmaton® cardioactive, a product designed foradults over 40 years of age, contains a blend of vitaminsand minerals combined with omega-3 fatty acids to helpmaintain cardiovascular health.pharmaton® kiddi®, a range of products designed forchildren, contains selected vitamins, minerals and the essentialamino acid lysine that are important during theperiod of growth. It is also recommended in the preventivetreatment of vitamin deficiencies.Urological diseasesBenign prostate hyperplasia (BPH) refers to an enlargementof the prostate in middle-aged and elderly men,which can lead to lower urinary tract symptoms (LUTS)such as frequent nighttime urination, urge to urinateevery few hours, weak flow and feeling of unfinishedurinating.84Boehringer Ingelheim annual report 2012